Two principal pathways are implicated in the estrogen formation in breast cancer tissues: the aromatase pathway, mediated by the enzyme CYP19-aromatase, which transforms androgen into estrogen, and the sulfatase pathway, which converts estrone into estrone sulfate by the enzyme sulfotransferase [2]. This evidence concerns the gene CYP19A1 and breast cancer.